More
    Guided Solutions - Connecting Talent With Innovation/div>

    Carmat implants Aeson artificial heart in patient

    Advanced total artificial heart designer and developer Carmat has announced the first Aeson heart implantation in a patient suffering from a cardiac tumour. The patient...

    RevBio to commence human trial for regenerative bone adhesive

    RevBio has secured approval from the US Food and Drug Administration to start a first-in-human clinical trial for its regenerative bone adhesive for cranial...

    GIE Medical enrolls first subject in trial of drug-coated balloon

    US-based clinical-stage company GIE Medical in the US has enrolled the first patient in the trial of a drug-coated balloon (DCB) for the treatment...

    Patient enrolment concludes in Neuspera System trial

    Neuspera Medical has concluded enrolment of patients and implant procedures for the SANS-UUI pivotal clinical study of its minimally invasive implant, Neuspera System. The implant...

    Alafair Biosciences’s VersaWrap device receives FDA 510(k) clearance

    Image credit: Alafair Biosciences/PRNewswire.Alafair Biosciences has received 510(k) clearance from the US Food and Drug Administration (FDA) for its VersaWrap class II medical device. The approval enables...

    BiVACOR wins IDE to start first-in-human study for artificial heart

    The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to BiVACOR’s total artificial heart (BTAH), greenlighting the way for...

    Paragonix completes first-in-human use of lung preservation system

    Paragonix Technologies has announced the completion of the world’s first-in-human use of the BAROguard Donor Lung Preservation System by Duke University Medical Center in the US. Earlier...

    Xeltis reveals 12-month trial data for aXess haemodialysis access graft

    The Netherlands-based medtech Xeltis has presented trial results for its aXess haemodialysis access graft showing 0% infection rates at 12 months. The data from the...

    Avation Medical confirm safety and efficacy data on smart bladder control system

    Avation Medical has announced positive results from the multi-centre trial of Vivally, its medical device to treat overactive bladder (OAB) syndrome.  The FREEOAB multi-centre study...

    Latest articles